Showing results (11-20 of 113) with videos related to
Sort By:
Pageof 12
NPJ Vaccines|September 23, 2022
Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunityCatherine Yankowski, Christoph Wirblich, Drishya Kurup, et al.Journal of Virology|December 21, 2007
The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spreadRojjanaporn Pulmanausahakul, Jianwei Li, Matthias J Schnell, et al.NPJ Vaccines|October 22, 2020
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2Drishya Kurup, Christoph Wirblich, Holly Ramage, et al.Current Opinion in Virology|February 13, 2019
Status of antiviral therapeutics against rabies virus and related emerging lyssavirusesVenice Du Pont, Richard K Plemper, Matthias J SchnellJournal of Immunological Methods|November 26, 2009
A novel composite immunotoxin that suppresses rabies virus production by the infected cellsTatiana Mareeva, Celestine Wanjalla, Matthias J Schnell, et al.Nature Reviews. Neuroscience|November 5, 2016
Keeping it in check: chronic viral infection and antiviral immunity in the brainKatelyn D Miller, Matthias J Schnell, Glenn F RallNature Reviews. Microbiology|February 27, 2018
The spread and evolution of rabies virus: conquering new frontiersChristine R Fisher, Daniel G Streicker, Matthias J SchnellClinics in Laboratory Medicine|September 25, 2002
HIV-1 vaccines: the search continuesJames P McGettigan, Philip M McKenna, Matthias J SchnellAnnual Review of Virology|March 10, 2016
Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask)Benjamin M Davis, Glenn F Rall, Matthias J SchnellViruses|October 14, 2011
Interferon response and viral evasion by members of the family rhabdoviridaeElizabeth J Faul, Douglas S Lyles, Matthias J SchnellPageof 12